Pfizer
PFE
PFE
2,773 hedge funds and large institutions have $90.1B invested in Pfizer in 2025 Q2 according to their latest regulatory filings, with 144 funds opening new positions, 1,158 increasing their positions, 1,219 reducing their positions, and 229 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
22% less call options, than puts
Call options by funds: $2.59B | Put options by funds: $3.32B
35% less funds holding in top 10
Funds holding in top 10: 43 → 28 (-15)
37% less first-time investments, than exits
New positions opened: 144 | Existing positions closed: 229
Holders
2,773
Holding in Top 10
28
Calls
$2.59B
Puts
$3.32B
Top Buyers
| 1 | +$502M | |
| 2 | +$256M | |
| 3 | +$247M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$190M |
| 5 |
Millennium Management
New York
|
+$158M |
Top Sellers
| 1 | -$642M | |
| 2 | -$371M | |
| 3 | -$331M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$324M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$271M |
